PORTLAND, OREGON, UNITED STATES, May 5, 2023 /EINPresswire.com/ — Interventional cardiology and peripheral vascular devices refer to medical devices used in diagnosing and treating cardiovascular and peripheral vascular diseases. These devices are designed to improve the efficiency and accuracy of the treatment while minimizing the risks associated with traditional surgical procedures.
๐๐๐๐จ๐ซ๐๐ข๐ง๐ ๐ญ๐จ ๐ซ๐๐๐๐ง๐ญ ๐ฆ๐๐ซ๐ค๐๐ญ ๐๐ฅ๐ฅ๐ข๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก, ๐ญ๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐ข๐ง๐ญ๐๐ซ๐ฏ๐๐ง๐ญ๐ข๐จ๐ง๐๐ฅ ๐๐๐ซ๐๐ข๐จ๐ฅ๐จ๐ ๐ฒ ๐๐ง๐ ๐ฉ๐๐ซ๐ข๐ฉ๐ก๐๐ซ๐๐ฅ ๐ฏ๐๐ฌ๐๐ฎ๐ฅ๐๐ซ ๐๐๐ฏ๐ข๐๐๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฌ๐ข๐ณ๐ ๐ฐ๐๐ฌ ๐ฏ๐๐ฅ๐ฎ๐๐ ๐๐ญ $17,960.8 ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง 2020. ๐๐ก๐ข๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ข๐ฌ ๐๐ฑ๐ฉ๐๐๐ญ๐๐ ๐ญ๐จ ๐๐ฑ๐ฉ๐๐ซ๐ข๐๐ง๐๐ ๐ฌ๐ข๐ ๐ง๐ข๐๐ข๐๐๐ง๐ญ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐ข๐ง ๐ญ๐ก๐ ๐๐จ๐ฆ๐ข๐ง๐ ๐ฒ๐๐๐ซ๐ฌ, ๐ฐ๐ข๐ญ๐ก ๐ ๐ฉ๐ซ๐จ๐ฃ๐๐๐ญ๐๐ ๐ฏ๐๐ฅ๐ฎ๐ ๐จ๐ $41,900.3 ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ 2030. ๐๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐ซ๐๐ฌ๐๐ง๐ญ๐ฌ ๐ ๐๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐ ๐๐ง๐ง๐ฎ๐๐ฅ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐ซ๐๐ญ๐ (๐๐๐๐) ๐จ๐ 8.5% ๐๐ซ๐จ๐ฆ 2021 ๐ญ๐จ 2030.
The increasing prevalence of cardiovascular diseases, such as coronary artery disease, heart failure, and peripheral artery disease, is a key factor driving the growth of the interventional cardiology and peripheral vascular devices market. In addition, technological advancements in medical devices, such as stents, catheters, and balloons, are making interventional procedures more efficient and effective, leading to increased adoption of these devices.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ ๐๐ซ๐จ๐๐ก๐ฎ๐ซ๐ ๐๐ญ: https://www.alliedmarketresearch.com/request-sample/1072
Key Market Players
1. Abbott Laboratories
2. B. Braun Melsungen AG
3. Boston Scientific
4. Becton
5. Dickinson and Company.
6. Cardinal Health
7. Cook Group
8. Medtronic plc
9. Terumo Group
10. Koninklijke Philips N.V.
11. Biotronik SE & Co. KG
๐๐ก๐ ๐ข๐ง๐ญ๐๐ซ๐ฏ๐๐ง๐ญ๐ข๐จ๐ง๐๐ฅ ๐๐๐ซ๐๐ข๐จ๐ฅ๐จ๐ ๐ฒ ๐๐ง๐ ๐ฉ๐๐ซ๐ข๐ฉ๐ก๐๐ซ๐๐ฅ ๐ฏ๐๐ฌ๐๐ฎ๐ฅ๐๐ซ ๐๐๐ฏ๐ข๐๐๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐๐๐ง ๐๐ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐๐ ๐๐ฒ ๐ญ๐ฒ๐ฉ๐ ๐๐ง๐ ๐๐ง๐-๐ฎ๐ฌ๐๐ซ.
By type, the market can be further divided into inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, accessories, angioplasty balloons, angioplasty stents, angioplasty catheters, and endovascular aneurysm repair stent grafts.
IVC filters are medical devices that are used to prevent blood clots from traveling from the lower extremities to the lungs, where they can cause serious health complications. Plaque modification devices, on the other hand, are designed to remove or modify plaque buildup in the arteries, which can lead to blockages and reduce blood flow. Hemodynamic flow alteration devices are used to improve blood flow by altering the shape or diameter of the blood vessel.
Angioplasty balloons, stents, and catheters are used in angioplasty procedures to open blocked or narrowed blood vessels in the heart and other parts of the body. Endovascular aneurysm repair stent grafts are used to treat abdominal aortic aneurysms by creating a new path for blood flow and preventing the aneurysm from rupturing.
By end-user, the market can be segmented into hospitals, ambulatory surgical centers, and others. Hospitals are the largest end-user of interventional cardiology and peripheral vascular devices, due to the high volume of interventional procedures performed in these facilities. Ambulatory surgical centers are also significant end-users, as they offer a more convenient and cost-effective alternative to hospital-based procedures.
Geographically, North America is the largest market for interventional cardiology and peripheral vascular devices, due to the high prevalence of cardiovascular diseases in the region and the presence of a well-established healthcare infrastructure. Europe is also a significant market, due to the growing aging population and the increasing demand for minimally invasive procedures. The Asia Pacific region is expected to experience the highest growth rate during the forecast period, due to the increasing incidence of cardiovascular diseases in the region and the growing demand for minimally invasive procedures.
๐๐ง๐ช๐ฎ๐ข๐ซ๐ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ฒ๐ข๐ง๐ : https://www.alliedmarketresearch.com/purchase-enquiry/1072
๐๐ก๐ ๐ข๐ง๐ญ๐๐ซ๐ฏ๐๐ง๐ญ๐ข๐จ๐ง๐๐ฅ ๐๐๐ซ๐๐ข๐จ๐ฅ๐จ๐ ๐ฒ ๐๐ง๐ ๐ฉ๐๐ซ๐ข๐ฉ๐ก๐๐ซ๐๐ฅ ๐ฏ๐๐ฌ๐๐ฎ๐ฅ๐๐ซ ๐๐๐ฏ๐ข๐๐๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐๐๐ง ๐๐ฅ๐ฌ๐จ ๐๐ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐๐ ๐๐ฒ ๐ซ๐๐ ๐ข๐จ๐ง, ๐ข๐ง๐๐ฅ๐ฎ๐๐ข๐ง๐ ๐๐จ๐ซ๐ญ๐ก ๐๐ฆ๐๐ซ๐ข๐๐, ๐๐ฎ๐ซ๐จ๐ฉ๐, ๐๐ฌ๐ข๐-๐๐๐๐ข๐๐ข๐, ๐๐ง๐ ๐๐๐๐๐.
North America is the largest market for interventional cardiology and peripheral vascular devices, with the United States accounting for a significant portion of the market share. The high prevalence of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, in the United States is a key driver of market growth in this region. Additionally, the region has a well-established healthcare infrastructure, which supports the adoption of advanced medical technologies, such as interventional cardiology and peripheral vascular devices.
Europe is also a significant market for interventional cardiology and peripheral vascular devices, with countries like Germany, France, and the United Kingdom leading the market. The region has a growing aging population, which is driving demand for minimally invasive procedures that improve quality of life. In addition, favorable government policies and reimbursement programs are supporting the adoption of interventional cardiology and peripheral vascular devices in this region.
The Asia-Pacific region is expected to experience the highest growth rate during the forecast period, due to the increasing incidence of cardiovascular diseases in the region and the growing demand for minimally invasive procedures. China, Japan, and India are the largest markets in this region, with increasing healthcare expenditure and growing healthcare infrastructure supporting market growth.
LAMEA, which includes Latin America, the Middle East, and Africa, is also a growing market for interventional cardiology and peripheral vascular devices. The region has a large population base and a high burden of cardiovascular diseases, which is driving demand for advanced medical technologies. In addition, increasing healthcare expenditure and improving healthcare infrastructure are supporting the adoption of interventional cardiology and peripheral vascular devices in this region.
๐๐๐๐๐๐๐๐ ๐ ๐๐๐ ๐๐๐๐๐๐: https://www.alliedmarketresearch.com/interventional-cardiology-and-peripheral-vascular-devices-market/purchase-options
David Correa
Allied Analytics LLP
+1-800-792-5285
email us here
